The FDA (food and drug administration) has issued a strict warning to Bayer to market the two aspirins carefully. The aspirins claim to strengthen the heart and make bones stronger. According to the federal regulators these are unsubstantiated claims and the marketing is illegal.
Two warning letters were issued to the company. They have been warned to issue proof with their pills, the Women’s low dose aspirin+ calcium and the Bayer Aspirin with Health advantage.
Bayer’s has advertised the pills as beneficent for thinning the blood and as a relief from aches and pains. Drugs for these ailments cannot be sold over the counter without a review by the government or scientists.
“The F.D.A. will take enforcement action against manufacturers found to be violating the law or attempting to circumvent the drug approval process,” said Michael A. Chappell, an F.D.A. associate commissioner.
“All of our communication on product benefits prominently features information for consumers to check with their physicians to determine if the product is right for them,” the company said in a statement. Bayer said it would respond to the letters in the next 15 business days, as requested by regulators
The company stands up to its claims and insists that no negative results have been reported so far. The FDA is firm in its belief that the two tablets claims should be tested and validated. The desires of FDA are not mandatory or enforceable by law.
